ArticleBMC infectious diseases2026
Staphylococcus aureus bacteremia: clinical outcomes and predictors of 28-day mortality in a tertiary-care cohort.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStaphylococcus aureus bacteremia (SAB) is associated with substantial short-term mortality, but the relative contributions of methicillin resistance, treatment adequacy, and host-related factors to outcome remain unclear. This study aimed to evaluate the clinical and microbiological characteristics of SAB, compare methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) episodes, and identify independent predictors of 28-day mortality in a Turkish tertiary-care cohort.
methodsThis retrospective cohort study included adult patients hospitalized with monomicrobial S. aureus bacteremia at Eskisehir Osmangazi University Faculty of Medicine Hospital between January 2019 and May 2023. Demographic, clinical, microbiological, and treatment-related data were collected retrospectively. Factors associated with 28-day all-cause mortality were assessed using univariable and multivariable logistic regression analyses.
resultsA total of 372 patients were included, of whom 293 (78.8%) had MSSA bacteremia and 79 (21.2%) had MRSA bacteremia. The two groups were comparable with respect to age, comorbidity burden, illness severity, and source or presumed focus of infection. Appropriate empirical therapy was significantly more frequent in MSSA than in MRSA bacteremia (90.8% vs. 44.3%, p < 0.001), and time to appropriate therapy was shorter in the MSSA group (median 0 vs. 2 days, p < 0.001). Despite these differences, mortality did not differ significantly between MSSA and MRSA bacteremia at 7 days (14.3% vs. 15.2%, p = 0.848), cumulative 14 days (16.7% vs. 16.5%, p = 0.955), or 28 days (30.7% vs. 27.8%, p = 0.620). Overall, 28-day mortality was 30.1% (112/372). In multivariable analysis, older age (OR 1.03, 95% CI 1.01-1.05; p = 0.014), higher Pitt Bacteremia Score (OR 1.76, 95% CI 1.41-2.20; p < 0.001), and intensive care unit (ICU) admission (OR 2.87, 95% CI 1.62-5.09; p < 0.001) were independently associated with 28-day mortality. Methicillin resistance, appropriateness of empirical therapy, and time to appropriate treatment were not independently associated with mortality.
conclusionsIn this cohort, short-term mortality in SAB was more strongly associated with host-related factors and acute illness severity than with methicillin resistance or treatment timing. Early risk stratification at the time of diagnosis may help guide the intensity of monitoring and management in patients with SAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.